Overview
Non-syndromic urogenital tract malformation (Orphanet code 165704) refers to a group of congenital structural abnormalities affecting the urinary and/or genital systems that occur in isolation, meaning they are not part of a recognized genetic syndrome or associated with malformations in other organ systems. These malformations encompass a wide spectrum of anatomical defects, including but not limited to renal agenesis, renal hypoplasia or dysplasia, duplex collecting systems, hydronephrosis due to ureteropelvic junction obstruction, vesicoureteral reflux, posterior urethral valves, hypospadias, cryptorchidism, and various uterine or vaginal anomalies. The severity ranges from mild conditions that may be incidentally discovered to life-threatening malformations that can impair renal function and require urgent intervention. These malformations primarily affect the kidneys, ureters, bladder, urethra, and reproductive organs. They are often detected prenatally through routine ultrasound screening or may present in infancy or childhood with urinary tract infections, voiding difficulties, or impaired kidney function. Some cases may not become apparent until adolescence or adulthood, particularly certain genital tract anomalies in females. The etiology is heterogeneous and may involve genetic factors, environmental influences, or a combination of both. Several genes involved in urogenital development (such as PAX2, HNF1B, RET, and others) have been implicated in some cases, though many remain without an identified genetic cause. Management depends on the specific type and severity of the malformation. Treatment options range from conservative monitoring and antibiotic prophylaxis for mild vesicoureteral reflux to surgical correction for obstructive uropathies, hypospadias, or complex renal anomalies. Long-term follow-up by a multidisciplinary team including pediatric urologists, nephrologists, and in some cases reproductive specialists is often necessary to monitor renal function and address complications. Early detection and appropriate intervention can significantly improve outcomes and quality of life.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Non-syndromic urogenital tract malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Non-syndromic urogenital tract malformation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Non-syndromic urogenital tract malformation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Non-syndromic urogenital tract malformation.
Community
No community posts yet. Be the first to share your experience with Non-syndromic urogenital tract malformation.
Start the conversation →Latest news about Non-syndromic urogenital tract malformation
No recent news articles for Non-syndromic urogenital tract malformation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Non-syndromic urogenital tract malformation
What is Non-syndromic urogenital tract malformation?
Non-syndromic urogenital tract malformation (Orphanet code 165704) refers to a group of congenital structural abnormalities affecting the urinary and/or genital systems that occur in isolation, meaning they are not part of a recognized genetic syndrome or associated with malformations in other organ systems. These malformations encompass a wide spectrum of anatomical defects, including but not limited to renal agenesis, renal hypoplasia or dysplasia, duplex collecting systems, hydronephrosis due to ureteropelvic junction obstruction, vesicoureteral reflux, posterior urethral valves, hypospadia
At what age does Non-syndromic urogenital tract malformation typically begin?
Typical onset of Non-syndromic urogenital tract malformation is neonatal. Age of onset can vary across affected individuals.